Senior insider sale
BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$1.50M
20K shares
What this filing means
SCOTT RANDAL W. plans to sell 20K shares of BRIDGEBIO PHARMA, INC. valued at approximately $1.50M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/17/2026ACC: 0001950047-26-001375
20K
Shares to sell
$1.50M
Approx. market value
20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
2/17/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Exercise of Stock Options Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20K
Market value
$1.50M
2/17/2026
Total
Units
20K
Value
$1.50M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/17/2026 | 20K | $1.50M | NASDAQ | Planned |
| Total | 20K | $1.50M | ||